Skip to content
Fencer Intel
medium 6.5

CVE-2026-21980 json

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform).

published 9mo ago modified 4mo ago also EUVD-2026-3532

cvss
6.5
version 3.1, CNA
cisa kev
Not listed
not in CISA's catalog
epss
0.2%
EPSS 0.2% chance of exploitation in 30 days, percentile 12%
public exploits
0
none known

Summary

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

Is CVE-2026-21980 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

CISA SSVC

Exploitation
none
Automatable
yes
Technical impact
partial
Assessed
9mo ago

Exploit prediction

0.22% chance of exploitation in the next 30 days, higher than 12% of all scored CVEs (FIRST EPSS, 2026-11-09).

CVSS scores

assigned by version score vector
CNA 3.1 6.5 CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

Affected products

  • Oracle Corporation Oracle Life Sciences Central Coding

References

Sources

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.